VC
Vimal Chopra
About Vimal Chopra
Data last updated:
Vimal Chopra is a Director at Epazote Pharmaceuticals Private Limited (since 2020) and Director at Glaxy-Gen Pharma Private Limited (since 2022). The companies operate in Chemicals. The largest current company by reported revenue is Epazote Pharmaceuticals Private Limited at ₹1.6 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2020 | 2020 | ₹1.6 Lakh (FY 2022) | Active | |
| Director | 08 Mar 2022 | 2022 | Active |
Board colleagues of Vimal Chopra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satyam Chopra | 10147119 | Epazote Pharmaceuticals Private Limited | Additional Director |
| Jasmine Kang | 09529586 | Glaxy-Gen Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vimal Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vimal Chopra
Vimal Chopra currently holds 2 directorships: Epazote Pharmaceuticals Private Limited (Director, since 01 Sep 2020, revenue ₹1.6 Lakh (FY 2022)); Glaxy-Gen Pharma Private Limited (Director, since 08 Mar 2022).
Vimal Chopra was first appointed on 01 Sep 2020 as Director at Epazote Pharmaceuticals Private Limited. The most recent appointment on record is 08 Mar 2022 at Glaxy-Gen Pharma Private Limited.
The current boards of Vimal Chopra's companies include Satyam Chopra (Epazote Pharmaceuticals Private Limited), Jasmine Kang (Glaxy-Gen Pharma Private Limited).